| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/19/1997 | CN1143386A Transforming growth factor alpha-H1 |
| 02/19/1997 | CN1143374A Non-viral vector |
| 02/19/1997 | CN1143373A 乙型肝炎疫苗 Hepatitis B Vaccine |
| 02/19/1997 | CN1143372A Haemopoietic manuration factor |
| 02/19/1997 | CN1143371A Corpuscles of stannius protein, stanniocalcin |
| 02/19/1997 | CN1143368A Agent for suppressing interference in immuno assaying |
| 02/19/1997 | CN1142973A Vaccine composition having antitumour activity and use thereof in therapy of malignant diseases |
| 02/19/1997 | CN1142895A Fungicidal compounds and its use |
| 02/19/1997 | CN1034080C Preparing method for insulin analogs |
| 02/19/1997 | CN1034079C Process for preparing nontoxic protein by puffing castor-bean dregs for detoxication |
| 02/19/1997 | CN1034054C Preparing method for improved oligosaccharide conjugate vaccines |
| 02/19/1997 | CA2183196A1 Nucleic acid sequence and plasmids comprising at least one phage resistance mechanism, bacteria containing them and their use |
| 02/18/1997 | USRE35457 Radiolabeling antibodies and other proteins with technetium or rhenium by regulated reduction |
| 02/18/1997 | US5604293 Wound healing and tissue repair |
| 02/18/1997 | US5604203 Analogs of peptide YY and uses thereof |
| 02/18/1997 | US5604201 Methods and reagents for inhibiting furin endoprotease |
| 02/18/1997 | US5604131 cDNA-genomic DNA hybrid sequence encoding APP770 containing a genomic DNA insert of the KI and OX-2 regions |
| 02/18/1997 | US5604121 Proteins with insecticidal properties against homopteran insects and their use in plant protection |
| 02/18/1997 | US5604117 Immunizing animal with specified peptide coupled to immunogenic carrier, preparing hybridoma producing monoclonal antibody, isolating antibody |
| 02/18/1997 | US5604116 Interleukin-3 (IL-3) multiple mutation polypeptides, recombinant production of the same, and corresponding therapeutic methods |
| 02/18/1997 | US5604115 Liver enriched transcription factor |
| 02/18/1997 | US5604114 Cis-acting repression sequences, cis-acting antirepression sequences, vectors, methods of preparation and use |
| 02/18/1997 | US5604107 Detection of neu p185 in cell lysates |
| 02/18/1997 | US5604106 Testing a body fluid sample with anti-autocrine motility factor antibody |
| 02/18/1997 | US5604102 Detecting and monitoring a terminal fragment of the beta-amyloid precursor protein produced by beta-secretase cleavage; alzheimer's disease |
| 02/18/1997 | US5604099 Treating sample with primers, nucleotide triphosphates and agents for polymerizing the triphosphates yields extension product of primer which separates from its complement on denaturing and acts as a template, amplification |
| 02/18/1997 | US5604094 Receptor-type phosphotyrosine phosphatase-β |
| 02/18/1997 | US5604093 Isolated new human herpes virus having morphology of human herpes virus and genomic double-stranded dna which hybridizes under stringent conditions with nucleic acid of specified molecular clone |
| 02/18/1997 | US5604091 Methods for protein binding enzyme complementation |
| 02/18/1997 | US5603951 Cyclosporin-containing soft capsule compositions |
| 02/18/1997 | US5603938 High molecular weight surface proteins of non-typeable haemophilus |
| 02/18/1997 | US5603934 Antigen recognized by patients with antibody associated paraneoplastic sensory neuronopathy |
| 02/18/1997 | US5603933 Peptides including sequence serine-arginine-arginine-serine; capable of binding to hiv glycoprotein |
| 02/18/1997 | US5603932 Receptor of the minor human rhinovirus receptor group |
| 02/13/1997 | WO1997005468A2 A confirmatory serodiagnostic assay for infectious diseases |
| 02/13/1997 | WO1997005285A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005266A1 Methods and means for targeted gene delivery |
| 02/13/1997 | WO1997005265A1 Transport proteins and their uses |
| 02/13/1997 | WO1997005263A1 Helper virus-free herpesvirus vector packaging system |
| 02/13/1997 | WO1997005262A1 Medicament containing at least one part of the ul84 protein of the cytomegalovirus, use of polypeptides corresponding to the amino acid sequence of the ul84 protein, and process for introducing ul84 into target cells |
| 02/13/1997 | WO1997005260A2 An expression control sequence for general and effective expression of genes in plants |
| 02/13/1997 | WO1997005259A1 Use of a prolactin receptor or growth hormone receptor intracytoplasmic domain for achieving protein secretion |
| 02/13/1997 | WO1997005258A2 Recombinant 60kda vegetable panallergen (co-factor-independent phosphoglycerate mutase; e.c. 5.4.2.1.) |
| 02/13/1997 | WO1997005256A2 Mammalian pro-hormone convertase |
| 02/13/1997 | WO1997005252A2 Chimeric receptors and methods for identifying compounds active at metabotropic glutamate receptors and the use of such compounds in the treatment of neurological disorders and diseases |
| 02/13/1997 | WO1997005251A2 Feline stem cell factor |
| 02/13/1997 | WO1997005250A2 Receptor ligand vegf-c |
| 02/13/1997 | WO1997005249A2 Extension of a protein-protein interaction surface to inactivate the function of a cellular protein |
| 02/13/1997 | WO1997005247A1 Transgenic 'knock out' mice expressing a human apolipoprotein e |
| 02/13/1997 | WO1997005244A1 Mocarhagin, a cobra venom protease, and therapeutic uses thereof |
| 02/13/1997 | WO1997005242A1 Novel replication competent human immunodeficiency virus type 2 (hiv-2) proviral clone designated hiv-2kr |
| 02/13/1997 | WO1997005241A2 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | WO1997005239A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | WO1997005169A1 Ha-2 antigenic peptide |
| 02/13/1997 | WO1997005168A1 The h-y antigen |
| 02/13/1997 | WO1997005167A1 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone |
| 02/13/1997 | WO1997005166A1 Transforming growth factor beta crystals |
| 02/13/1997 | WO1997005165A1 Protein with plant protecting properties |
| 02/13/1997 | WO1997005164A1 Papillomavirus polyprotein constructs |
| 02/13/1997 | WO1997005159A2 Method for the purification of proteins |
| 02/13/1997 | WO1997005158A1 Compositions, treatments, and diagnostics for schistosomiasis and related diseases |
| 02/13/1997 | WO1997005157A1 Gene encoding the human homolog of mad2 |
| 02/13/1997 | WO1997004814A1 Detecting prions in a sample and prion preparation and transgenic animal used for same |
| 02/13/1997 | WO1997004810A1 Dax-1 protein, methods for production and use thereof |
| 02/13/1997 | WO1997004805A1 Genetically engineered chimeric viruses for the treatment of diseases associated with viral transactivators |
| 02/13/1997 | WO1997004802A1 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 02/13/1997 | WO1997004798A1 H-y derived epitopes and uses therefor |
| 02/13/1997 | WO1997004796A1 Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations |
| 02/13/1997 | WO1997004794A1 Modulators of expression and function of lrp in alzheimer's disease |
| 02/13/1997 | WO1997004748A2 Enhanced artificial viral envelopes for cellular delivery of therapeutic substances |
| 02/13/1997 | WO1997004658A1 Herpes simplex virus 1 entry into cells mediated by a novel member of the tnf/ngf receptor family |
| 02/13/1997 | WO1997004647A1 Methods of detecting duplication mutated fibrillin-1 gene and compositions and methods of using the same |
| 02/13/1997 | WO1996040951A3 Use of ovary-tissue transcriptional factors |
| 02/13/1997 | WO1996035779A3 Method for activating a reversibly inactivated immobilized enzyme by release from an immobilising moiety and its use in nucleicacid amplification reactions |
| 02/13/1997 | WO1996035774A3 Angiostatin fragments and aggregate angiostatin and methods of use |
| 02/13/1997 | WO1996032133A3 Conjugate for treating inflammatory, infectious and/or skin diseases |
| 02/13/1997 | WO1996017933A3 Dna encoding a cell growth inhibiting factor and its product |
| 02/13/1997 | WO1996013583A3 Targeted hetero-association of recombinant proteins to multi-functional complexes |
| 02/13/1997 | WO1996002572A3 Antigenic polypeptide sequence of factor viii, fragments and/or epitopes thereof |
| 02/13/1997 | WO1995027071A3 An adenovirus supervector system |
| 02/13/1997 | DE19600357C1 DNA-Sequenz kodierend einen Phosphoenolpyruvat-Phosphat-Translokator, Plasmide, Bakterien, Hefen und Pflanzen enthaltend diesen Transporter DNA sequence encoding a phosphoenolpyruvate-phosphate translocator, plasmids, bacteria, yeasts and plants containing these transporters |
| 02/13/1997 | CA2246561A1 Modulators of expression and function of lrp in alzheimer's disease |
| 02/13/1997 | CA2228727A1 Use of a prolactin receptor or growth hormone receptor intracytoplasmic domain for achieving protein secretion |
| 02/13/1997 | CA2228374A1 Extension of a protein-protein interaction surface to inactivate the function of a cellular protein |
| 02/13/1997 | CA2228248A1 Receptor ligand vegf-c |
| 02/13/1997 | CA2228176A1 Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| 02/13/1997 | CA2227988A1 Mammalian pro-protein converting enzyme |
| 02/13/1997 | CA2227980A1 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone |
| 02/13/1997 | CA2227972A1 Mocarhagin, a cobra venom protease and therapeutic uses thereof |
| 02/13/1997 | CA2227786A1 Transport proteins and their uses |
| 02/13/1997 | CA2227769A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227694A1 Methods and compositions for identifying morphogen analogs |
| 02/13/1997 | CA2227328A1 Detecting prions in a sample and prion preparation and transgenic animal used for same |
| 02/13/1997 | CA2227327A1 Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
| 02/13/1997 | CA2227007A1 Transgenic "knock out" mice expressing a human apolipoprotein e |
| 02/13/1997 | CA2226860A1 Novel replication competent human immunodeficiency virus type 2 (hiv-2) proviral clone designated hiv-2kr |
| 02/13/1997 | CA2226080A1 Method for the purification of proteins |
| 02/13/1997 | CA2224909A1 Ha-2 antigenic peptide |
| 02/13/1997 | CA2224907A1 Methods and means for targeted gene delivery |
| 02/13/1997 | CA2224894A1 The h-y antigen |